Scientists have identified a new drug that could prevent or mitigate the consequences derived from infection by SARS-CoV-2, the virus responsible for Covid-19.

Preliminary results of the study conducted on animal models showed that the drug 4-Phenylbutiric acid (4-PBA) fully curbs mortality caused by respiratory failure derived from cellular stress, showed the research published in the journal Cytokine and Growth Factors Review.